. The appearances were considered to be compatible with a perivenous encephalomyelitis seen following viral infections. Multiple sclerosis (MS) was thought to be less likely, because of the uneven distribution of the areas of demyelination.
She was treated with pulsed high dose intravenous methylprednisolone, but in spite of this her condition continued to deteriorate over the next two weeks. She developed a complete bulbar palsy, with loss of all tongue and palate movements, left hemiparesis with loss of posterior column sensation in the left arm, a conjugate gaze palsy to the left, left facial weakness, and defective upgaze. Repeat MRI showed an increase in the size of the pontomedullary mass, particularly on the left, and confirmed that the biopsy site was from within the lesion. She was treated with a further course of high dose intravenous methylprednisolone, in combination with antibiotics and acyclovir. Subsequent viral serology, which included herpes simplex and zoster, was negative.
Over the next year there was a gradual improvement in her clinical state. After two months, she was successfully weaned from daytime positive pressure ventilation, but has continued to require nocturnal ventilation. After 18 months, she still has severe disequilibrium and limb ataxia, and had required epiglottic plication and cricopharyngeal myotomy to prevent recurrent aspiration pneumonia to severe bulbar weakness. Repeat MRI after three months showed a marked reduction in size of the original lesion with loss of mass effect.
Discussion
This patient presented with a subacute brainstem syndrome, and MRI revealed a solitary, enhancing, mass lesion. The differential diagnosis included glioma, lymphoma, or granuloma. A biopsy was performed which showed perivenous inflammation and demyelination suggestive of ADEM.
For several reasons, ADEM was considered unlikely in the initial differential diagnosis. Firstly, there was no history of a preceding infection. A prior clinical infection occurs in most but not all ADEM cases. Secondly, the MRI features were unusual for ADEM in that there was mass effect, and only one lesion.
Mass lesions do occasionally occur in ADEM, both in the cerebral hemispheres and spinal cord,4 although this is the first reported case we know of with a brainstem mass. Also, while there are usually multiple cerebral white matter lesions on MRI in ADEM,'2 this is not invariably the case. 5 The evolution of the MR lesion in our patient is certainly typical of an inflammatory/ demyelinating CNS lesion. Enhanced CT or MRI characteristically show blood-brain barrier impairment in acutely symptomatic lesions both in MS6 and ADEM.7 In MS, gadolinium enhancement has been correlated with perivascular inflammation,8 and it is likely that the same applies to ADEM. The subsequent reduction in size is also characteristic of inflammatory/demyelinating CNS lesions,9 and is probably due mainly to resolution of oedema, although a degree of remyelination is not excluded.
Although acyclovir was given, the pathological features and negative viral serology make it unlikely that this was brainstem encephalitis due to herpes simplex. We consider that it is best regarded as a localised form of ADEM, akin to the well recognised syndromes of post-infectious transverse myelitis and optic neuritis, in which immunopathogenic mechanisms are probably important. Transverse myelitis may also occur without evidence of disseminated MR white matter lesions.2 1011 Another possibility is that this was the first episode of MS. However, this seems less likely since there were no oligoclonal bands in the CSF, there was no MR evidence for disseminated lesions, and the pathological features were more typical of ADEM than MS.
This case emphasises that ADEM should be considered in the differential diagnosis of subacute MR enhancing brainstem masses.
